about
Macrophage Migration Inhibitory Factor in Clinical Kidney DiseaseRole of T cells in type 2 diabetic nephropathyCelastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db miceLipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusSirt6 deficiency results in progression of glomerular injury in the kidneySerpinC1/Antithrombin III in kidney-related diseasesTLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney diseasePodocytes, signaling pathways, and vascular factors in diabetic kidney diseaseThe effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat.Inflammation in diabetic kidney diseaseEffects of 1,25-(OH)(2)D (3) on the expressions of vitamin D receptor, STAT5 and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes patients and diabetic nephropathy patients with uremia.Increased IL-12 and decreased IL-33 serum levels are associated with increased Th1 and suppressed Th2 cytokine profile in patients with diabetic nephropathy (CURES-134)Inflammatory cytokines in diabetic nephropathy.Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.Dual-color immunofluorescent labeling with quantum dots of the diabetes-associated proteins aldose reductase and Toll-like receptor 4 in the kidneys of diabetic rats.HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucoseThe association between interleukin-19 concentration and diabetic nephropathy.FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity.Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE MiceMaternal Obesity Promotes Diabetic Nephropathy in Rodent OffspringDefining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge.The MIF receptor CD74 in diabetic podocyte injury.Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?Inflammation as a Therapeutic Target for Diabetic Neuropathies.Role of mindin in diabetic nephropathy.Role of Toll-like receptors in diabetic nephropathy.Pentoxifylline for Diabetic Nephropathy: an Important Opportunity to Re-purpose an Old Drug?The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice.Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy.Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis.Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians.Regulatory T cells in Acute and Chronic Kidney Diseases.Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-κB pathway.Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose‑treated HK‑2 cells.
P2860
Q26767479-197CFA92-8E13-45A6-9D3A-39DF4CB51E64Q26849691-5410BA0F-1E86-44D9-B404-95091082DEE4Q27323293-830228C0-A121-4900-BC58-750714539885Q28080521-B43EA042-680B-48B5-B2C5-D26271411F5DQ33563525-09D7C969-1732-4FA4-89E8-9EAC5C468215Q33578786-1BB3B84A-1042-454E-9C4B-3EF802D128ACQ33633050-7EC11E4B-EBB7-4DED-B243-F0DAC235B804Q33783045-912D6473-C47C-431A-AF67-D7B5B08A9B4BQ33801646-FC8259EC-23CF-431D-9A9E-AC6C2AA6EE91Q33821237-5BA76AE3-118C-45E9-A9DE-4182A283E975Q33861166-9C4C7A55-6D00-414D-AED0-3A80CB05F602Q34023543-A01BF521-E4F3-4B43-8AB0-E25C4A949FCCQ34155747-1BDE9141-7FE0-4A32-B135-4FA9E7D7481BQ34732819-175A4B83-E3FF-496D-88EC-22897EF22DB8Q35133177-276D5A74-51E2-487F-85AB-AB0A28A5E56BQ35312128-66021D1D-B1DD-40E8-8612-416161F1DBF1Q35654369-76EEDA45-8B6E-45B7-A4B8-7B7F14E8ACDDQ35919099-E6A6A140-4C55-490B-BCF4-10CD9381E947Q36281625-43B68EC7-6049-45D3-A804-936F082D5751Q36294501-74AF3632-C874-4910-867C-23DBFC126C12Q36347614-EF50A124-F28B-41C5-8A54-A8BA988CF87DQ36424155-A970CE81-1700-4715-B9DD-0822CE68C16FQ36986185-119F2F86-86BB-4000-A8D6-90940D66CDD8Q37003822-598A53AB-A2FA-4B98-8F81-06D6A1D5CC6AQ37086644-D6D9A848-E9B0-454A-8E78-EB313C66D8DAQ37392107-A3A9AD6E-8759-4FEA-9E67-47DBA89E226EQ37450547-65B7E1AF-C225-4EF5-96C9-AC90AD576CA1Q37974895-E0D3ACEC-E42B-4C03-87A4-6DE0C9A64570Q38184614-C7CA3B52-554E-47C0-BC29-126B451D1EA0Q38690856-46F82992-310C-498F-8E72-003EE9DF60EAQ39168114-3398BBCA-2C1F-4219-9EBC-9CB11B99DD77Q39286825-125DC300-B3E6-4DA6-BC79-26321139EEF8Q39496640-AF1D6C5E-6164-4818-8FAA-5F313B591248Q42371220-FE979B81-27E4-472E-9716-D3A46CA34CD1Q43960965-5F13B416-238F-4D6A-A740-D505B2B57947Q45025014-45A89931-5532-4990-8131-369803CEA871Q45066685-386897A8-6EA5-476B-9F0A-B70E5FB4C672Q46453523-50FECF7E-1C1F-4558-A0AB-55AE67964A85Q47141766-8224135A-0EF6-42A1-91ED-A0A845A75605Q47321983-2DA8B6E7-3261-4E01-AC56-DD8547D7F827
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inflammation and diabetic nephropathy.
@ast
Inflammation and diabetic nephropathy.
@en
type
label
Inflammation and diabetic nephropathy.
@ast
Inflammation and diabetic nephropathy.
@en
prefLabel
Inflammation and diabetic nephropathy.
@ast
Inflammation and diabetic nephropathy.
@en
P2860
P1476
Inflammation and diabetic nephropathy.
@en
P2093
Carmen Mora
Juan F Navarro
P2860
P2888
P304
P356
10.1007/S11892-006-0080-1
P577
2006-12-01T00:00:00Z